Market Closed -
NSE India S.E.
12:43:49 26/04/2024 BST
|
5-day change
|
1st Jan Change
|
1,507
INR
|
-0.89%
|
|
-1.07%
|
+19.62%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,148,922
|
845,286
|
1,434,322
|
2,194,737
|
2,358,729
|
3,614,718
|
-
|
-
|
Enterprise Value (EV)
1 |
1,131,107
|
797,926
|
1,363,238
|
2,077,371
|
2,269,278
|
3,516,740
|
3,453,474
|
3,389,927
|
P/E ratio
|
43.1
x
|
22.5
x
|
49.4
x
|
67.3
x
|
27.8
x
|
38.5
x
|
32
x
|
27.9
x
|
Yield
|
0.57%
|
0.28%
|
1.25%
|
1.09%
|
1.17%
|
0.82%
|
0.95%
|
1.05%
|
Capitalization / Revenue
|
3.95
x
|
2.57
x
|
4.28
x
|
5.68
x
|
5.37
x
|
7.45
x
|
6.71
x
|
6.09
x
|
EV / Revenue
|
3.89
x
|
2.43
x
|
4.07
x
|
5.37
x
|
5.17
x
|
7.25
x
|
6.41
x
|
5.72
x
|
EV / EBITDA
|
17.9
x
|
11.4
x
|
16.1
x
|
20
x
|
19.5
x
|
27
x
|
22.9
x
|
19.9
x
|
EV / FCF
|
-111
x
|
15.9
x
|
27.3
x
|
27.7
x
|
79
x
|
38.3
x
|
32.9
x
|
27.4
x
|
FCF Yield
|
-0.9%
|
6.28%
|
3.67%
|
3.61%
|
1.27%
|
2.61%
|
3.04%
|
3.65%
|
Price to Book
|
2.77
x
|
1.87
x
|
3.09
x
|
4.57
x
|
4.21
x
|
5.74
x
|
5.1
x
|
4.51
x
|
Nbr of stocks (in thousands)
|
2,399,335
|
2,399,335
|
2,399,335
|
2,399,276
|
2,399,276
|
2,399,335
|
-
|
-
|
Reference price
2 |
478.8
|
352.3
|
597.8
|
914.8
|
983.1
|
1,507
|
1,507
|
1,507
|
Announcement Date
|
28/05/19
|
27/05/20
|
27/05/21
|
30/05/22
|
26/05/23
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
290,659
|
328,375
|
334,981
|
386,545
|
438,857
|
485,376
|
538,436
|
593,106
|
EBITDA
1 |
63,076
|
69,898
|
84,914
|
103,977
|
116,468
|
130,488
|
150,584
|
170,076
|
EBIT
1 |
45,543
|
49,370
|
64,114
|
82,540
|
91,174
|
105,609
|
124,494
|
143,136
|
Operating Margin
|
15.67%
|
15.03%
|
19.14%
|
21.35%
|
20.78%
|
21.76%
|
23.12%
|
24.13%
|
Earnings before Tax (EBT)
1 |
38,102
|
50,096
|
27,994
|
44,813
|
94,084
|
111,522
|
132,525
|
152,917
|
Net income
1 |
26,654
|
37,649
|
29,038
|
32,727
|
84,736
|
93,041
|
112,656
|
129,651
|
Net margin
|
9.17%
|
11.47%
|
8.67%
|
8.47%
|
19.31%
|
19.17%
|
20.92%
|
21.86%
|
EPS
2 |
11.11
|
15.69
|
12.10
|
13.60
|
35.30
|
39.08
|
47.04
|
54.08
|
Free Cash Flow
1 |
-10,164
|
50,128
|
50,002
|
74,895
|
28,738
|
91,808
|
104,885
|
123,789
|
FCF margin
|
-3.5%
|
15.27%
|
14.93%
|
19.38%
|
6.55%
|
18.91%
|
19.48%
|
20.87%
|
FCF Conversion (EBITDA)
|
-
|
71.72%
|
58.89%
|
72.03%
|
24.67%
|
70.36%
|
69.65%
|
72.78%
|
FCF Conversion (Net income)
|
-
|
133.14%
|
172.2%
|
228.85%
|
33.91%
|
98.67%
|
93.1%
|
95.48%
|
Dividend per Share
2 |
2.750
|
1.000
|
7.500
|
10.00
|
11.50
|
12.37
|
14.35
|
15.86
|
Announcement Date
|
28/05/19
|
27/05/20
|
27/05/21
|
30/05/22
|
26/05/23
|
-
|
-
|
-
|
Fiscal Period: March |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
88,368
|
85,230
|
97,187
|
96,259
|
98,631
|
94,468
|
107,618
|
109,523
|
112,410
|
109,307
|
119,408
|
120,786
|
122,741
|
122,051
|
128,044
|
EBITDA
1 |
24,061
|
20,484
|
28,211
|
26,299
|
26,063
|
23,404
|
28,844
|
29,566
|
30,037
|
28,021
|
33,318
|
32,390
|
33,096
|
31,971
|
-
|
EBIT
1 |
18,742
|
14,950
|
23,179
|
20,996
|
20,526
|
17,839
|
22,964
|
23,466
|
23,438
|
21,306
|
26,804
|
23,673
|
27,405
|
24,698
|
27,293
|
Operating Margin
|
21.21%
|
17.54%
|
23.85%
|
21.81%
|
20.81%
|
18.88%
|
21.34%
|
21.43%
|
20.85%
|
19.49%
|
22.45%
|
19.6%
|
22.33%
|
20.24%
|
21.32%
|
Earnings before Tax (EBT)
1 |
21,630
|
9,030
|
18,042
|
22,865
|
24,662
|
-20,756
|
22,848
|
24,124
|
24,715
|
22,397
|
24,811
|
26,568
|
27,807
|
28,313
|
-
|
Net income
1 |
18,525
|
8,942
|
14,442
|
20,470
|
20,588
|
-22,772
|
20,609
|
22,622
|
21,660
|
19,845
|
20,225
|
23,123
|
24,062
|
23,668
|
-
|
Net margin
|
20.96%
|
10.49%
|
14.86%
|
21.27%
|
20.87%
|
-24.11%
|
19.15%
|
20.66%
|
19.27%
|
18.16%
|
16.94%
|
19.14%
|
19.6%
|
19.39%
|
-
|
EPS
2 |
7.720
|
3.700
|
6.000
|
-
|
8.600
|
-9.500
|
8.600
|
9.400
|
9.000
|
8.300
|
8.400
|
8.650
|
9.793
|
9.800
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
29/01/21
|
27/05/21
|
30/07/21
|
02/11/21
|
31/01/22
|
30/05/22
|
29/07/22
|
01/11/22
|
31/01/23
|
26/05/23
|
03/08/23
|
-
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
17,814
|
47,360
|
71,085
|
117,366
|
89,450
|
97,978
|
161,244
|
224,791
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-10,164
|
50,128
|
50,002
|
74,895
|
28,738
|
91,808
|
104,885
|
123,789
|
ROE (net income / shareholders' equity)
|
9.25%
|
8.69%
|
6.33%
|
16.6%
|
16.6%
|
15.5%
|
16.3%
|
16.8%
|
ROA (Net income/ Total Assets)
|
5.71%
|
5.66%
|
4.27%
|
11.4%
|
11.5%
|
11.1%
|
12.1%
|
12.5%
|
Assets
1 |
466,880
|
664,736
|
679,574
|
286,936
|
739,147
|
839,649
|
930,327
|
1,040,930
|
Book Value Per Share
2 |
173.0
|
189.0
|
194.0
|
200.0
|
233.0
|
262.0
|
295.0
|
334.0
|
Cash Flow per Share
2 |
9.150
|
27.30
|
25.70
|
37.30
|
20.70
|
43.10
|
49.90
|
56.00
|
Capex
1 |
32,128
|
15,420
|
11,701
|
14,950
|
20,856
|
17,219
|
18,258
|
18,633
|
Capex / Sales
|
11.05%
|
4.7%
|
3.49%
|
3.87%
|
4.75%
|
3.55%
|
3.39%
|
3.14%
|
Announcement Date
|
28/05/19
|
27/05/20
|
27/05/21
|
30/05/22
|
26/05/23
|
-
|
-
|
-
|
Last Close Price
1,507
INR Average target price
1,574
INR Spread / Average Target +4.46% Consensus |
1st Jan change
|
Capi.
|
---|
| +19.62% | 43.34B | | +20.44% | 21.96B | | +10.86% | 14.09B | | +13.07% | 13.64B | | +37.46% | 11.43B | | -8.59% | 6.86B | | -0.05% | 6.79B | | -8.87% | 5.73B | | +8.46% | 5.22B | | -4.29% | 4.71B |
Generic Pharmaceuticals
|